Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic SyndromesCristina Astrid Tentori, Olivier Nibourel, Victor Savevski et al.|Journal of Clinical Oncology|2024Cited by 39
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic SyndromesMatteo Zampini, Matteo Giovanni Della Porta, Elena Riva et al.|Journal of Clinical Oncology|2025Cited by 13
A Comprehensive, Artificial Intelligence, Digital Twin Platform Based on Multimodal Real-World Data Integration for Personalized Medicine in HematologySaverio D’Amico, Matteo Della Porta, Elisabetta Sauta et al.|Blood|2024Cited by 5
Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and MicrosimulationCaterina Gregorio, Francesca Ieva, Marta Spreafico et al.|JCO Clinical Cancer Informatics|2024Cited by 4
Enhancing Personalized Prognostic Assessment of Myelodysplastic Syndromes through a Multimodal and Explainable Deep Data Fusion Approach (MAGAERA)Elisabetta Sauta, Matteo Giovanni Della Porta, Luca Lanino et al.|Blood|2024Cited by 2